|Articles|March 15, 2002
- BioPharm International-03-15-2002
- Volume 15
- Issue 3
Outsourcing Outlook: Using Earned-Value Analysis for Better Project Management
Author(s)Jim Miller, Heather B. Hayes
by Heather B Hayes, a freelance writer, and Jim Miller, publisher of the Bio/Pharmaceutical Outsourcing Report EVA allows project managers to refer to tangible numbers, not just a gut feeling, in determining whether a project is advancing on time and within budget.
Advertisement
Articles in this issue
over 23 years ago
Inside Washington: Biotech Manufacturing ? Obstacle or Opportunity?over 23 years ago
Guest Editorial: Warning Letters ? A Symptom?over 23 years ago
The Importance of Freezing on Lyophilization Cycle Developmentover 23 years ago
Business Benefits of Computer Systems Validationover 23 years ago
A System Developer's Approach to ValidationNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Regulatory Uncertainty Surfaces as FDA Blames COVID Vaccines for 10 Child Deaths
5
